Catalyst Wire Dossier Catalyst Wire Dossier

Travoprost/brinzolamide fixed-dose combination ophthalmic suspension

travoprost/brinzolamide fixed-dose combination · Alcon Research
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Travoprost/brinzolamide fixed-dose combination ophthalmic suspension, covering 2012-04-16 to 2012-04-16. Get the full timeline:

Most recent: Clinical Trial Update: IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

See pricing